These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 36427344

  • 21. Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States.
    Tepper SJ, Fang J, Zhou L, Shen Y, Vo P, Abdrabboh A, Glassberg MB, Ferraris M.
    J Manag Care Spec Pharm; 2021 Sep; 27(9):1157-1170. PubMed ID: 33998825
    [Abstract] [Full Text] [Related]

  • 22. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    Rubin DT, Mittal M, Davis M, Johnson S, Chao J, Skup M.
    J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
    [Abstract] [Full Text] [Related]

  • 23. Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder.
    Ta JT, Sullivan SD, Tung A, Oliveri D, Gillard P, Devine B.
    J Manag Care Spec Pharm; 2021 Feb; 27(2):223-239. PubMed ID: 33506730
    [Abstract] [Full Text] [Related]

  • 24. Patient Characteristics, Health Care Resource Utilization, and Costs Associated with Treatment-Regimen Failure with Biologics in the Treatment of Psoriasis.
    Foster SA, Zhu B, Guo J, Nikai E, Ojeh C, Malatestinic W, Goldblum O, Kornberg LJ, Wu JJ.
    J Manag Care Spec Pharm; 2016 Apr; 22(4):396-405. PubMed ID: 27023693
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Early weight gain predicts later weight gain in depressed patients treated with antidepressants: Findings from the METADAP cohort.
    Asmar KE, Fève B, Colle R, Gressier F, Vievard A, Trabado S, Verstuyft C, Haffen E, Polosan M, Ferreri F, Falissard B, Chanson P, Becquemont L, Corruble E.
    J Affect Disord; 2018 Dec 01; 241():22-28. PubMed ID: 30092445
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Optimal treatment sequence for targeted immune modulators for the treatment of moderate to severe ulcerative colitis.
    Bloudek LM, Pandey R, Fazioli K, Ollendorf DA, Carlson JJ.
    J Manag Care Spec Pharm; 2021 Aug 01; 27(8):1046-1055. PubMed ID: 34337994
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Patterns of Adherence to Oral Atypical Antipsychotics Among Patients Diagnosed with Schizophrenia.
    MacEwan JP, Forma FM, Shafrin J, Hatch A, Lakdawalla DN, Lindenmayer JP.
    J Manag Care Spec Pharm; 2016 Nov 01; 22(11):1349-1361. PubMed ID: 27783548
    [Abstract] [Full Text] [Related]

  • 34. Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
    Vogelzang NJ, Pal SK, Ghate SR, Li N, Swallow E, Peeples M, Zichlin ML, Meiselbach MK, Perez JR, Agarwal N.
    J Manag Care Spec Pharm; 2018 Jun 01; 24(6):525-533. PubMed ID: 29799328
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Treatment patterns and health care costs among patients with psoriatic arthritis treated with biologic or targeted synthetic disease-modifying antirheumatic drugs.
    Murage MJ, Princic N, Park J, Malatestinic WN, Zhu B, Atiya B, Kern SA, Stenger KB, Sprabery AT, Ogdie A.
    J Manag Care Spec Pharm; 2022 Feb 01; 28(2):206-217. PubMed ID: 35098751
    [Abstract] [Full Text] [Related]

  • 37. Health care utilization and costs associated with functional status in patients with psoriatic arthritis.
    Ogdie A, Hwang M, Veeranki P, Portelli A, Sison S, Shafrin J, Pedro S, Hass S, Hur P, Kim N, Yi E, Michaud K.
    J Manag Care Spec Pharm; 2022 Sep 01; 28(9):997-1007. PubMed ID: 36001101
    [Abstract] [Full Text] [Related]

  • 38. Predictive factors for hyperglycaemic progression in patients with schizophrenia or bipolar disorder.
    Kusumi I, Arai Y, Okubo R, Honda M, Matsuda Y, Matsuda Y, Tochigi A, Takekita Y, Yamanaka H, Uemura K, Ito K, Tsuchiya K, Yamada J, Yoshimura B, Mitsui N, Matsubara S, Segawa T, Nishi N, Sugawara Y, Kako Y, Shinkawa I, Shinohara K, Konishi A, Iga J, Hashimoto N, Inomata S, Tsukamoto N, Ito H, Ito YM, Sato N.
    BJPsych Open; 2018 Nov 01; 4(6):454-460. PubMed ID: 30450224
    [Abstract] [Full Text] [Related]

  • 39. Prevalence and Cost of Subsequent Fractures Among U.S. Patients with an Incident Fracture.
    Weaver J, Sajjan S, Lewiecki EM, Harris ST, Marvos P.
    J Manag Care Spec Pharm; 2017 Apr 01; 23(4):461-471. PubMed ID: 28345441
    [Abstract] [Full Text] [Related]

  • 40. Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States.
    Lu M, Oladapo A, Wu Y, Farahbakhshian S, Ewenstein B.
    J Manag Care Spec Pharm; 2021 Feb 01; 27(2):175-185. PubMed ID: 33307935
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.